Related Experiment Videos
Prognostic factors in bladder cancer. A pathologic, immunohistochemical, and DNA flow-cytometric study
A Lopez-Beltran1, G A Croghan, I Croghan
1Unit of Anatomical Pathology, University of Cordoba, Spain.
American Journal of Clinical Pathology
|July 1, 1994
Summary
This study on bladder cancer found that high grade and advanced stage tumors correlate with DNA aneuploidy, impacting patient survival. Immunohistochemical markers also show predictive value for bladder cancer outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Bladder cancer prognosis is complex.
- Accurate prediction of patient survival is crucial for effective treatment planning.
Purpose of the Study:
- To identify key features for assessing bladder cancer patient survival.
- To evaluate the combined predictive value of tumor characteristics, immunohistochemistry, and DNA ploidy.
Main Methods:
- Analysis of 36 bladder cancer cases.
- Assessment of pathologic grade and stage.
- Immunohistochemical analysis of eight cell and tumor markers.
- DNA ploidy analysis.
Main Results:
- High grade and advanced stage tumors correlated with DNA aneuploidy.
- Low grade and early stage tumors correlated with DNA diploidy.
- Blood group isoantigen A correlated with DNA ploidy in deceased patients.
- Blood group isoantigen H and oncogene-related protein p21 correlated with DNA ploidy in surviving patients.
Conclusions:
- Pathologic grade and stage are significant predictors of bladder cancer survival.
- Immunohistochemical markers (blood group isoantigens A and H, p21) offer additional prognostic value.
- Simultaneous evaluation of DNA ploidy with these markers enhances bladder cancer survival prediction.